HomeSYNACT • STO
add
SynAct Pharma AB
Previous close
kr 18.96
Day range
kr 19.00 - kr 19.40
Year range
kr 13.40 - kr 25.30
Market cap
1.03B SEK
Avg Volume
151.38K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.72M | 10.91% |
Net income | -22.93M | -24.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 53.41M | -12.75% |
Total assets | 220.52M | -18.48% |
Total liabilities | 50.23M | -10.87% |
Total equity | 170.29M | — |
Shares outstanding | 53.33M | — |
Price to book | 5.94 | — |
Return on assets | -23.96% | — |
Return on capital | -30.89% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -22.93M | -24.76% |
Cash from operations | -23.96M | -34.79% |
Cash from investing | — | — |
Cash from financing | -147.00K | -100.37% |
Net change in cash | -24.53M | -207.97% |
Free cash flow | -15.42M | -178.05% |
About
Founded
Mar 14, 2012
Website
Employees
8
